Page last updated: 2024-09-05

solifenacin succinate and ipratropium bromide anhydrous

solifenacin succinate has been researched along with ipratropium bromide anhydrous in 1 studies

Compound Research Comparison

Studies
(solifenacin succinate)
Trials
(solifenacin succinate)
Recent Studies (post-2010)
(solifenacin succinate)
Studies
(ipratropium bromide anhydrous)
Trials
(ipratropium bromide anhydrous)
Recent Studies (post-2010) (ipratropium bromide anhydrous)
5221943431717

Protein Interaction Comparison

ProteinTaxonomysolifenacin succinate (IC50)ipratropium bromide anhydrous (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.0021
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0028
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antón, F; Beleta, J; Buil, MA; Cárdenas, A; Casals, G; Castro, J; Córdoba, M; Espinosa, S; Fernández, MD; Ferrer, M; Gavaldà, A; González, M; Huerta, JM; López, M; Miralpeix, M; Monleón, JM; Prat, M; Ramos, I; Ryder, H; Segarra, V; Tort, L; Vilella, D1

Other Studies

1 other study(ies) available for solifenacin succinate and ipratropium bromide anhydrous

ArticleYear
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
    Bioorganic & medicinal chemistry letters, 2011, Jun-01, Volume: 21, Issue:11

    Topics: Carbamates; Drug Discovery; Humans; Inhibitory Concentration 50; Microsomes, Liver; Molecular Structure; Muscarinic Antagonists; Quaternary Ammonium Compounds; Quinuclidines; Time Factors

2011